WUGEN Expands Leadership Team with Appointment of a Vice President of Research and Development and a Vice President of Product Development

ST. LOUIS, March 26, 2019 /PRNewswire/ — WUGEN Inc., a biotechnology company developing a novel, universal allogeneic CAR-T therapy platform, today announced the appointment of Ayman Kabakibi, Ph.D., as Vice President of Research and Development, and Kenneth Chrobak, Ph.D., as Vice President of Product Development. “The experience and talent that Ayman and Ken bring to WUGEN strengthen our ability to …

WUGEN Expands Leadership Team with Appointment of a Vice President of Research and Development and a Vice President of Product Development Read More »